The flow cytometric crossmatch (FCXM) is a crucial component of the pre-transplant workup to detect donor-specific antibodies (DSA) in recipient serum. To define the statistical cutoff for positivity, the standard deviation (SD) of the median channel shift (MCS) between two negative control sera crossmatched against a panel of donor lymphocyte samples is used. In samples with low lymphocyte counts, the accuracy and precision of the MCS measurements may be compromised, possibly affecting the MCS at which the positive cutoff should be set. We therefore investigated whether the number of B-and T-lymphocyte events analyzed by FCXM impacted the distribution of MCS values. Methods: Fifty lymphocyte samples separated from peripheral blood or lymph node were treated in parallel with two negative control (non-HLA sensitized) sera and analyzed on a FC500 flow cytometer (Beckman Coulter) with stains for CD3, CD19, and anti-IgG to detect cell-bound DSA.
Introduction:
The flow cytometric crossmatch (FCXM) is a crucial component of the pre-transplant workup to detect donor-specific antibodies (DSA) in recipient serum. To define the statistical cutoff for positivity, the standard deviation (SD) of the median channel shift (MCS) between two negative control sera crossmatched against a panel of donor lymphocyte samples is used. In samples with low lymphocyte counts, the accuracy and precision of the MCS measurements may be compromised, possibly affecting the MCS at which the positive cutoff should be set. We therefore investigated whether the number of B-and T-lymphocyte events analyzed by FCXM impacted the distribution of MCS values. Methods: Fifty lymphocyte samples separated from peripheral blood or lymph node were treated in parallel with two negative control (non-HLA sensitized) sera and analyzed on a FC500 flow cytometer (Beckman Coulter) with stains for CD3, CD19, and anti-IgG to detect cell-bound DSA.
CD3-and CD19-positive T-and B-lymphocytes, respectively, were separately gated and plotted against the event count parameter, which was used to define subpopulations of cells containing varying numbers of T cells (first 1,000, 2,000, 3,000, 4,000, 5,000 events) and B cells (first 100, 250, 500, 750 and 1,000 events), which encompass the low end of the range of cells acquired in routine practice. For each event count-gated subpopulation of all samples, the median fluorescence of the anti-IgG signal for the two negative control sera was obtained, and these values were subtracted to calculate the MCS. The SD of MCS values obtained from all samples for T-and B-lymphocytes were calculated at each event count. Results: With all events included, the SD for the MCS values calculated from the included samples were 48. 
